Charles River Laboratories ROE 2010-2024 | CRL

Current and historical return on equity (ROE) values for Charles River Laboratories (CRL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Charles River Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $0.44B $3.65B 12.85%
2023-12-31 $0.47B $3.60B 14.27%
2023-09-30 $0.47B $3.31B 14.97%
2023-06-30 $0.48B $3.26B 16.12%
2023-03-31 $0.50B $3.11B 17.40%
2022-12-31 $0.49B $2.98B 17.83%
2022-09-30 $0.44B $2.63B 16.70%
2022-06-30 $0.44B $2.65B 17.31%
2022-03-31 $0.42B $2.62B 17.04%
2021-12-31 $0.39B $2.54B 16.49%
2021-09-30 $0.40B $2.43B 17.48%
2021-06-30 $0.40B $2.32B 18.57%
2021-03-31 $0.38B $2.19B 18.83%
2020-12-31 $0.36B $2.12B 19.59%
2020-09-30 $0.30B $1.90B 17.32%
2020-06-30 $0.27B $1.76B 16.46%
2020-03-31 $0.25B $1.66B 15.78%
2019-12-31 $0.25B $1.64B 16.71%
2019-09-30 $0.23B $1.54B 16.24%
2019-06-30 $0.22B $1.46B 16.11%
2019-03-31 $0.23B $1.40B 17.74%
2018-12-31 $0.23B $1.32B 18.51%
2018-09-30 $0.14B $1.26B 11.83%
2018-06-30 $0.13B $1.19B 11.73%
2018-03-31 $0.13B $1.14B 12.34%
2017-12-31 $0.12B $1.05B 12.56%
2017-09-30 $0.20B $1.03B 21.35%
2017-06-30 $0.18B $0.97B 20.69%
2017-03-31 $0.17B $0.88B 19.26%
2016-12-31 $0.16B $0.84B 18.61%
2016-09-30 $0.14B $0.87B 17.58%
2016-06-30 $0.14B $0.84B 18.39%
2016-03-31 $0.16B $0.78B 21.11%
2015-12-31 $0.15B $0.74B 21.27%
2015-09-30 $0.15B $0.71B 21.02%
2015-06-30 $0.14B $0.71B 20.56%
2015-03-31 $0.13B $0.67B 18.72%
2014-12-31 $0.13B $0.68B 18.50%
2014-09-30 $0.12B $0.67B 17.53%
2014-06-30 $0.12B $0.68B 17.48%
2014-03-31 $0.11B $0.70B 16.43%
2013-12-31 $0.10B $0.64B 15.94%
2013-09-30 $0.10B $0.66B 16.04%
2013-06-30 $0.09B $0.65B 14.97%
2013-03-31 $0.10B $0.63B 16.01%
2012-12-31 $0.10B $0.60B 16.53%
2012-09-30 $0.11B $0.60B 18.69%
2012-06-30 $0.10B $0.57B 18.65%
2012-03-31 $0.10B $0.56B 18.79%
2011-12-31 $0.11B $0.53B 19.61%
2011-09-30 $-0.26B $0.54B -43.94%
2011-06-30 $-0.31B $0.59B -42.47%
2011-03-31 $-0.32B $0.56B -35.17%
2010-12-31 $-0.34B $0.69B -30.01%
2010-09-30 $0.02B $1.04B 1.85%
2010-06-30 $0.09B $1.39B 6.25%
2010-03-31 $0.11B $1.38B 7.87%
2009-12-31 $0.11B $1.37B 8.73%
Sector Industry Market Cap Revenue
Medical Medical Services $11.456B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $118.753B 14.48
Cencora (COR) United States $45.072B 17.57
ICON (ICLR) Ireland $27.369B 24.59
DiDi Global (DIDIY) China $17.109B 0.00
Avantor (AVTR) United States $15.195B 22.37
CochLear (CHEOY) Australia $14.677B 0.00
Viatris (VTRS) United States $13.931B 4.16
Revvity (RVTY) United States $13.772B 24.16
Natera (NTRA) United States $13.029B 0.00
Medpace Holdings (MEDP) United States $11.839B 35.92
Solventum (SOLV) United States $10.033B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $9.918B 0.00
Sonic Healthcare (SKHHY) Australia $8.114B 0.00
HealthEquity (HQY) United States $6.801B 43.67
Bausch + Lomb (BLCO) Canada $5.689B 22.77
Organon (OGN) United States $5.563B 5.28
Doximity (DOCS) United States $5.170B 36.21
PACS (PACS) United States $5.142B 0.00
Life Times (LTH) United States $4.112B 43.08
Sotera Health (SHC) United States $3.787B 18.58
Surgery Partners (SGRY) United States $3.772B 34.51
GoodRx Holdings (GDRX) United States $3.366B 128.14
Agilon Health (AGL) United States $2.780B 0.00
Progyny (PGNY) United States $2.664B 45.87
AMN Healthcare Services Inc (AMN) United States $2.344B 9.29
Premier (PINC) United States $2.118B 9.06
BrightSpring Health Services (BTSG) United States $2.063B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.871B 0.00
Alignment Healthcare (ALHC) United States $1.776B 0.00
Teladoc Health (TDOC) United States $1.565B 0.00
Establishment Labs Holdings (ESTA) $1.315B 0.00
CareDx (CDNA) United States $0.959B 0.00
Embecta (EMBC) United States $0.943B 6.41
GeneDx Holdings (WGS) United States $0.884B 0.00
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.653B 0.00
Pediatrix Medical (MD) United States $0.646B 6.86
Sharecare (SHCR) United States $0.500B 0.00
Enhabit (EHAB) United States $0.498B 49.65
COMPASS Pathways (CMPS) United Kingdom $0.475B 0.00
Sonida Senior Living (SNDA) United States $0.446B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.331B 6.20
DocGo (DCGO) United States $0.330B 18.06
LifeMD (LFMD) United States $0.283B 0.00
MultiPlan (MPLN) United States $0.281B 0.00
Sera Prognostics (SERA) United States $0.258B 0.00
Beauty Health (SKIN) United States $0.224B 0.00
Ascend Wellness Holdings (AAWH) United States $0.207B 0.00
Biodesix (BDSX) United States $0.187B 0.00
So-Young (SY) China $0.097B 47.00
Pono Capital Two (PTWO) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.043B 5.79
Oncology Institute (TOI) United States $0.042B 0.00
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.037B 0.00
Nutex Health (NUTX) United States $0.037B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.023B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.019B 0.00
TRxADE HEALTH (MEDS) United States $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
XWELL (XWEL) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
Aclarion (ACON) United States $0.003B 0.00